⌘K

Login Start Free

Home/Filings/4/0001140361-11-033273

4//SEC Filing

Lalach Harvey 4

Accession 0001140361-11-033273

CIK 0001314052other

View on SEC.gov Company Profile

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 7:33 PM ET

Size

11.8 KB

Accession

0001140361-11-033273

Insider Transaction Report

Form 4

Period: 2011-06-13

ANAVEX LIFE SCIENCES CORP.AVXL

DirectorPresident CEO CFO

Transactions

Sale
common stock
2011-06-14$2.90/sh−3,200$9,280→ 574,572 total
Sale
common stock
2011-06-15$2.81/sh−3,000$8,430→ 568,572 total
Sale
common stock
2011-06-13$3.05/sh−2,100$6,405→ 577,772 total
Sale
common stock
2011-06-15$2.84/sh−3,000$8,520→ 571,572 total

Holdings

common stock
579,872
stock options
Exercise: $3.10From: 2008-06-03Exp: 2013-06-03→ common stock (150,000 underlying)
150,000
stock options
Exercise: $3.50From: 2010-06-29Exp: 2015-06-29→ common stock (50,000 underlying)
200,000

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

ANAVEX LIFE SCIENCES CORP.

CIK 0001314052

Entity typeother

Related Parties

1

filerCIK 0001360545

Filing Metadata

Form type: 4
Filed: Jun 15, 8:00 PM ET
Accepted: Jun 16, 7:33 PM ET
Size: 11.8 KB

View on SEC.gov